The Atlas will enable the validation of genetic targets and training of AI models at unprecedented scale SAN DIEGO, Jan. 13, 2026 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) today introduced the world’s largest genome-wide genetic perturbation dataset, being built to accelerate drug…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
